Therabene Alternatives & Competitors
12 companies similar to Therabene — Pioneering PROTAC Molecules for Cancer and Autoimmune Disease Treatment with Col...
Companies similar to Therabene
Bioniz, LLC
Pioneering the future of autoimmune and cancer treatment with innovative small peptides an...
SFA Therapeutics
A New Paradigm in Drug Development
Thetis Pharmaceuticals
Resolving disease without compromising host defense
MEDIBIOFARMA SL
To make disease-modifying treatments available to patients with serious or life-threatenin...
Rival Readout
Competing with Therabene? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Biond Biologics Ltd
Biond - Innovative immunotherapies and a pioneering intracellular delivery for biologics f...
Alder Biopharmaceuticals
Dedicated to alleviating human suffering with safer and better antibody therapeutics throu...
Flexus Biosciences
Bristol-Myers Squibb acquired Flexus for $800M upfront & $450M in potential earnouts in 20...
Arvinas
Leading the way in targeted protein degradation therapeutics
Alzprotect SAS
Therapeutic Solutions for Neurodegeneration
Telormedix
Pioneering targeted immunity for cancer and autoimmune disease treatment through innovativ...
Bright Peak Therapeutics
Better Biologics Through Chemistry
Polymed Biopharmaceuticals
Polymed creates novel PROTAC therapies for cancers and immunology HPB-143 (IRAK4) & HPB-...
About Therabene
Therabene is a biotechnology firm founded in 2020, specializing in the development of PROTAC molecules for addressing cancer and autoimmune diseases. Led by experienced executive Dr. Mario DiPaola, with a notable 25-year career in the biotechnology and pharmaceutical sectors, the company emphasizes collaborative effort...
PROTAC Molecules, Cancer Treatment, Autoimmune Disease Treatment, Collaborative Vision, Dr. Mario DiPaola, Pharmaceutical Industry, Biopharmaceutical Industry, Biotech Industry, Academic Research Institutions, Clinical Research Institutions, Partnerships, Disease-specific Assets, Biotech Collaborations, Specialized Drug Development
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Therabene: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Therabene on 13 Sep 2024. The 12 companies listed here were last checked between 12 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.